Evidence map›Paper›PMID 27057270›Full record

ArticleOxidative medicine and cellular longevity2016

Propofol Suppressed Hypoxia/Reoxygenation-Induced Apoptosis in HBVSMC by Regulation of the Expression of Bcl-2, Bax, Caspase3, Kir6.1, and p-JNK.

Jianhai Zhang, Yunfei Xia, Zifeng Xu, Xiaoming Deng

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Crosstalk of the Caspase Family and Mammalian Target of Rapamycin Signaling.International journal of molecular sciences · 2021
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Effects of Different Processed Products ofEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Jianhai ZhangDepartment of Anesthesiology, Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai 200080, China.
Yunfei XiaDepartment of Anesthesiology, Shanghai International Medical Center, Shanghai 201318, China.
Zifeng XuDepartment of Anesthesiology, International Peace Maternal and Child Health Hospital, Shanghai Jiao Tong University, Shanghai 200030, China.
Xiaoming DengDepartment of Anesthesiology, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai 200433, China.
International Peace Maternity & Child Health Hospital · CNSecond Military Medical University · CNShanghai First People's Hospital · CNShanghai International Medical Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have found that propofol may protect brain from cerebral ischemic-reperfusion injury. However, the underlying mechanism remains unclear. The effects of propofol were evaluated in HBVSMC after hypoxia/reoxygenation (H/R). Cell viability and levels of SOD, LDH, and MDA were measured. Apoptosis was detected by flow cytometry. The levels of Bax, Bcl-2, Caspase3, Sur2b, Kir6.1, JNK, p-JNK, mTOR, and p-mTOR proteins were measured by western blotting. H/R decreased cell viability and SOD activity and increased LDH leakage and MDA content in HBVSMC, all of which were significantly reversed by propofol. Propofol suppressed the levels of H/R-induced apoptosis. The expression of Bcl-2 and p-mTOR was significantly downregulated and the expression levels of Bax, Caspase3, Kir6.1, and p-JNK were upregulated following H/R injury. The ratio of p-JNK/JNK was increased; however, that of p-mTOR/mTOR decreased correspondingly. The effects on the expression of these proteins were reversed by propofol treatment. SP600125 enhanced and Everolimus attenuated the effect of propofol. These findings suggested that the protective effect of propofol against H/R injury in the HBVSMC was through the inhibition of apoptosis by inducing the expression of Bcl-2 and p-mTOR as well as inhibiting the expression levels of Bax, Caspase3, Kir6.1, and p-JNK.

Indexed as

Cell HypoxiaAnthracenesApoptosisbcl-2-Associated X ProteinBlotting, WesternCaspase 3Cell LineEnzyme-Linked Immunosorbent AssayEverolimusHumansJNK Mitogen-Activated Protein KinasesKATP ChannelsL-Lactate DehydrogenaseMalondialdehydeOxygenPropofolAnthracenesbcl-2-Associated X ProteinCaspase 3EverolimusJNK Mitogen-Activated Protein KinasesKATP ChannelsL-Lactate DehydrogenaseMalondialdehydeOxygenPropofolProto-Oncogene Proteins c-bcl-2pyrazolanthroneSuperoxide DismutaseTubulinuK-ATP-1 potassium channel

Identifiers

PMID27057270
PMCPMC4736333
OpenAlexW2226060322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.